Monday, November 6, 2017
Pharmaleads CEO to Present at Bio-Europe 2017
PL265 is being developed for the
treatment
of neuropathic
pain
(oral) and ocular
pain
/dry eye syndrome (eye drops). PL37 is being developed for the ...
read more...
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment